BioInnova

What BioInnova does

BioInnova Pty Ltd is an Australian specialty bio-pharmaceutical company headquartered in North Rocks, NSW, that operates an integrated services platform spanning the pharmaceutical product lifecycle. The company offers eight core service lines: pharmaceutical contract manufacturing (delivered through long-term partnerships with Contract Manufacturing Organizations worldwide), drug development and testing, R&D to commercialization (covering biologicals and bio-similars), product development, laboratory analytical services with QA support, ANZ-focused regulatory services, clinical study project management, and sales, marketing, and distribution.

Technically, BioInnova holds GMP and GLP compliance credentials enabling cGMP manufacturing transfers and pharmaceutical-grade quality assurance activities. The company does not own manufacturing facilities directly, instead leveraging a global CMO partnership network to provide manufacturing capacity across multiple dosage forms. Distribution is anchored by a company-owned pharmaceutical warehouse and storage facility in NSW, Australia.

Commercially, BioInnova operates a sales-led, enterprise-field-sales go-to-market targeting pharmaceutical companies as the primary customer segment, with hospitals and medical practitioners as a secondary segment. Revenue is generated through professional services fees (contract manufacturing, drug development, regulatory) and transaction-based distribution income. Pricing is quote-based and not publicly disclosed. The company maintains marketing and distribution presence across six countries — Australia, New Zealand, India, USA, Fiji, and Papua New Guinea — and claims exports across five continents. BioInnova is privately held with no disclosed funding rounds, no named customers, and no public revenue figures.

Name

BioInnova

Legal name

BioInnova Pty Ltd

Website

https://bioinnova.com.au

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

BioInnova Pty Ltd is an Australian specialty bio-pharmaceutical services company offering integrated contract manufacturing, drug development, regulatory (ANZ), and distribution services to pharmaceutical companies globally, leveraging CMO partnerships and a six-country distribution footprint.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing & Services

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Pharmaceutical Preparation Manufacturing (325412), Scientific Research and Development Services (5417)

SIC

Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Biologic API/Drug Substance Manufacturing Services (HLAAAKAA)

akta.pro secondary industries

Biosimilar Development & Clinical/Regulatory Services (comparability, trials, pharmacovigilance) (HLAAAHAJ), Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling) (HLAAAJAF)

Keywords

• Pharmaceutical contract manufacturing
• Drug development services
• Regulatory affairs consulting
• Pharmaceutical distribution services
• Biological bio-similar products

Headquarters

HQ city

Sydney

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Pharmaceutical Contract Manufacturing: BioInnova provides contract manufacturing services for pharmaceutical products through long-term partnerships with CMO facilities worldwide. The company offers manufacturing expertise covering a range of product types and dosage forms with cGMP compliance.
2. Drug Development and Testing Services: Comprehensive drug development services including R&D to commercialization support for biological and pharmaceutical products, laboratory analytical services, QA support, and regulatory services primarily for the ANZ market.
3. Sales, Marketing and Distribution: Distribution of pharmaceutical products through the company's own warehouse facility in NSW, Australia and distribution network. Exports to five continents with marketing presence across Australia, New Zealand, India, USA, Fiji, and Papua New Guinea.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels1 record

Core offering

BioInnova is a specialty bio-pharmaceutical company providing integrated pharmaceutical contract manufacturing, drug development, regulatory, and distribution services for biological and bio-similar products. The company partners with global CMO facilities for manufacturing, offers R&D through commercialisation support, ANZ-focused regulatory services, and distributes pharmaceutical products from its NSW warehouse to customers across five continents.

Product overview

BioInnova is a specialty bio-pharmaceutical company offering a unified service platform for pharmaceutical product development and commercialization. The company's integrated service portfolio includes: Pharmaceutical Contract Manufacturing, Drug Development and Testing, R&D to Commercialisation (Biologicals and Bio-similers), Product Development, Laboratory Analytical Service/QA and Support, Regulatory Service (ANZ), Project Management (Clinical Studies), and Sales/Marketing/Distribution. These services work together to support clients from early-phase product development through regulatory approvals to commercial distribution, covering the entire pharmaceutical lifecycle.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical Contract Manufacturing
• Drug Development and Testing Comprehensive drug development and testing services with decades of hands-on development experience across complex technologies and the complete scale of finished dosage forms. Targeted at pharmaceutical companies needing development expertise.
• R&D to Commercialisation (Biologicals and Bio-similars) Full execution and support for the development of any finished dosage form, formula, or process, including transfer and scale-up to cGMP manufacturing facilities. Designed for pharmaceutical companies developing biological and bio-similar products.
• Product Development Transforms promising molecules into products, keeping up with medical trends and technology to improve patient health. Targeted at large and small pharmaceutical companies needing product development support.
• Laboratory Analytical Service, QA and Support GLP and GMP services including auditing, inspection preparation, remediation, and QA support, with emphasis on quality and fast turnaround times. Designed for pharmaceutical companies requiring quality assurance and laboratory testing.
• Regulatory Service (ANZ) End-to-end regulatory support including local agent representation, strategic submission planning, due-diligence, global regulatory submissions, clinical services, and manufacturing facility audits for Australian and New Zealand markets. Targeted at pharmaceutical companies seeking ANZ market entry.
• Project Management (Clinical Studies) Project management experience with advanced technologies and processes, delivering clinical study projects with minimized risk and high quality standards. Targeted at pharmaceutical companies conducting clinical studies.
• Sales, Marketing and Distribution Pharmaceutical warehouse and storage facility in NSW, Australia with a professionally run distribution network across five continents, serving hospitals, GPs, and clients. Targeted at pharmaceutical companies requiring global distribution capabilities.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• CMO Facilities (Contract Manufacturing Organizations)coreStrategic or Co-development PartnerBioInnova maintains long-term partnerships with contract manufacturing organizations (CMOs) across the world covering a range of product types and dosage forms. These partnerships provide manufacturing expertise ensuring reliable delivery of products on time while maintaining the highest level of safety in testing, manufacturing, and transferring of products.

Scale indicators3 records

Recent moves5 records

Expansion highlights3 records

Direct peers

• IDT Australia: Australian specialty pharmaceutical manufacturer offering contract manufacturing, drug development, and regulatory services. Highly comparable to BioInnova's integrated pharma services model and ANZ market focus.
• Mayne Pharma: Australia-based specialty pharmaceutical company with contract development and manufacturing operations, generic and branded drug portfolios, and distribution across multiple geographies—directly analogous to BioInnova's positioning.
• Novotech: Asia-Pacific focused CRO providing clinical trial and regulatory services for pharmaceutical and biotech clients. Comparable to BioInnova's clinical project management and ANZ regulatory service lines.

Broad incumbents

• Catalent: Global CDMO offering development, manufacturing, and biologics services across a much broader portfolio than BioInnova; represents the scaled incumbent whose offering BioInnova mirrors at a regional level.
• Patheon (Thermo Fisher): Global CDMO within Thermo Fisher providing end-to-end pharmaceutical development, manufacturing, and distribution services. Sets the benchmark for integrated bio-pharma services that BioInnova attempts regionally.
• IQVIA: Global CRO and life sciences services firm with regulatory, clinical, and commercialization capabilities. Comparable to BioInnova's drug development, regulatory, and distribution services at enterprise scale.

Emerging players

• Clinuvel Pharmaceuticals: Australian specialty pharmaceutical company developing and commercializing biological products globally. Comparable in geographic footprint, biologics focus, and pharmaceutical distribution model.
• Starpharma: Australian biotech focused on dendrimer-based pharmaceutical products. Comparable as an ANZ-headquartered specialty bio-pharma with biological product development, though operating in its own product R&D rather than services.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioInnova